Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ATLAS Biolabs and Ingenuity® Systems Sign Collaboration Agreement

Published: Wednesday, June 20, 2012
Last Updated: Tuesday, June 19, 2012
Bookmark and Share
ATLAS Biolabs complements its bioinformatics portfolio with Ingenuity® Variant Analysis™ and Ingenuity® iReport™ for comprehensive data analysis and interpretation.

ATLAS Biolabs and Ingenuity® Systems have signed a collaboration agreement that gives customers of ATLAS Biolabs the option to analyze and interpret their study data using Ingenuity solutions.

Ingenuity Variant Analysis will be used to identify causal variants from the output of whole genome and exome sequencing experiments and iReport will be used for the biological interpretation of RNA-Seq and other gene expression data.

Both solutions leverage the Ingenuity Knowledge Base, a repository of biological interactions and functional annotations created from millions of individually modelled relationships between proteins, genes, complexes, cells, tissues, metabolites, drugs, and diseases.

By offering the Ingenuity products, ATLAS Biolabs supports the complete workflow from project design to scientific analysis, providing its customers with high quality laboratory and bioinformatic services.

“The Ingenuity products facilitate and accelerate the bioinformatics support we provide to our customers. They allow us and our customer to interactively manoeuvre through the data and shed light on it from multiple biological perspectives, to understand the biological meaning.” explains Dr. Karsten R. Heidtke, Head of Bioinformatics at ATLAS Biolabs.

“We are very pleased to partner with ATLAS Biolabs in Europe to offer a complete “sample to insight” solution to ATLAS Biolabs’ customers combining ATLAS Biolabs’ lab services with Ingenuity’s analysis and biological interpretation solution,” stated Sean Scott, Sr. Vice President, Global Commercial Operations, Ingenuity Systems.

Scott continued, “By providing Ingenuity iReport and Ingenuity Variant Analysis, ATLAS Biolabs can support researchers working with RNA-Seq and DNA resequencing data, so that they can quickly and reliably understand the underlying biology of their experiments.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ATLAS Biolabs has Licensed Cartagenia Software for Analysis and Interpretation of Genetic Data
ATLAS Biolabs expands its services for the evaluation of genetic data obtained by DNA chip analysis.
Friday, October 01, 2010
Scientific News
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Spotting DNA Repair Genes Gone Awry
Ludwig researchers develop a two-pronged approach for identifying genes responsible for fixing DNA damage that can trigger cancer when compromised.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!